Liquidia logo
Liquidia
LQDA | NASDAQ
Chart Builder DCF Calculator
$56.37
-$1.04 (-1.81%)
At close: Nov 16, 2026, 4:00 PM ET
$56.30
-$0.07 (-0.12%)
After-hours: Nov 16, 2026, 7:47 PM ET

Liquidia Company Profile

Company profile explained

Company Profile

Liquidia Corporation operates as a biopharmaceutical enterprise, concentrating on the development, production, and market introduction of various treatments aimed at fulfilling critical patient requirements throughout the United States. A key asset in its developmental portfolio is YUTREPIA, an innovative inhaled dry powder version of treprostinil, intended for managing pulmonary arterial hypertension. Beyond its pipeline, the company also distributes a generic treprostinil injection within the U.S. market. Founded in 2004, Liquidia Corporation's main office is located in Morrisville, North Carolina.

Key Executives

Name Position
Roger A. Jeffs Chief Executive Officer & Director
Michael Kaseta Chief Operating Officer & Chief Financial Officer
Christian Perez Font Senior Vice President, Chief Compliance Officer & Associate General Counsel
Dana Boyle Chief Accounting Officer
Jason Adair Chief Business Officer
Matt Snow Senior Vice President of Sales
Michael Post Senior Vice President of Marketing
Rajeev Saggar Chief Medical Officer
Russell Schundler General Counsel & Corporate Secretary
Sarah Krepp SPHR Chief Human Resources Officer
Scott Moomaw Chief Commercial Officer

Latest SEC Filings

Date Type Title
Oct 28, 2026 4 Filing
Oct 28, 2026 4 Filing
Oct 14, 2026 8-K Current Report
Oct 13, 2026 4 Filing
Oct 13, 2026 4 Filing
Oct 13, 2026 4 Filing
Oct 13, 2026 4 Filing
Oct 13, 2026 4 Filing
Oct 13, 2026 4 Filing
Oct 13, 2026 4 Filing
View All SEC Filings ➞
Liquidia
Liquidia logo
Country United States
IPO Date Jul 26, 2018
Industry Medical - Pharmaceuticals
Sector Healthcare
Employees 216
CEO Roger A. Jeffs

Contact Details

419 Davis Drive Morrisville, North Carolina 27560 United States

Stock Details

Ticker Symbol LQDA
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001819576
CUSIP Number 53635D202
ISIN Number US53635D2027
SIC Code 2834

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.